Breast cancer — any cancer — can be incredibly stressful under the best of circumstances. BCRF Scientific Director & Dana-Farber Cancer Institute's Dr. Judy Garber explains what patients and families should consider in this time of the coronavirus.

Dr. Judy Garber: Breast Cancer Care and COVID-19: From the Frontlines

Breast cancer—and any cancer—can be incredibly stressful under the best of circumstances for patients, survivors, and their families. In this time of the novel coronavirus (COVID-19), concerns can feel like they’re rising exponentially. So, what do we all need to know? With tons of new information bombarding us at once, what should cancer patients and families consider? Are there practical tactics or is there tangible guidance to stay safe?

In this special episode of Investigating Breast Cancer, I spoke with Dr. Judy Garber for the answers. Dr. Garber is BCRF’s scientific director and chief of the Division of Cancer Genetics and Prevention at the Dana-Farber Cancer Institute in Boston. Dr. Garber is also a Professor of Medicine at Harvard Medical School, a past president of the American Association for Cancer Research, and a member of the National Cancer Advisory Board. She served on the Board of Scientific Counselors of the National Cancer Institute and has been a BCRF Investigator since 2001.